Dr. Linda Garland is a thoracic medical oncologist and cancer researcher at the University of Arizona Banner Health. She has expertise in lung cancer and pleural mesothelioma and is particularly interested in the use of experimental therapeutics to improve patient outcomes. Education and Career Dr. Garland earned her medical degree at the University of Texas Health
Dr. Helen J. Ross is a medical oncologist specializing in the treatment of lung cancer and pleural mesothelioma at Rush University Cancer Center in Chicago, Illinois. In addition to her role as professor of Internal Medicine, Oncology, and as Interim Chief of the Division of Hematology, Oncology, and Cellular Therapy, she is also the Director
Dr. Evan Osmundson is a radiation oncologist specializing in lung cancer, mesothelioma, and thoracic cancers at Vanderbilt University Medical Center in Nashville, Tennessee. He is highly skilled in the use of innovative radiation treatments, including 3D conformal radiation, adaptive radiotherapy, Intensity-Modulated Radiation Therapy (IMRT), Stereotactic Body Radiotherapy, Stereotactic Radiosurgery, Total Body Radiation, and Total Skin
Dr. Andreas Saltos is a board-certified medical oncologist at the Moffitt Cancer Center in Tampa, Florida. He specializes in treating patients with thoracic malignancies, including those diagnosed with malignant pleural mesothelioma and all types of lung cancer. Education and Career Dr. Saltos earned his medical degree at the University of Maryland Medical Center in Baltimore,
Dr. Eric Luk is a medical oncologist and hematologist treating patients at the Messino Cancer Center in western North Carolina. He specializes in the treatment of aggressive thoracic malignancies, including malignant pleural mesothelioma, as well as head and neck cancers. Education and Career Dr. Luk earned his medical degree at Tulane University School of Medicine
Dr. Jeffrey P. Ward is a physician-scientist at the Siteman Cancer Center and Washington University School of Medicine with a particular interest in thoracic oncology. His patient care is focused on treating patients diagnosed with lung cancer and other thoracic malignancies. He works to leverage innovations, including immunotherapy treatments, to more effectively manage lung cancer.
Dr. Mark A. Socinski is a medical oncologist and Executive Director of the AdventHealth Cancer Institute in Orlando, Florida. He specializes in thoracic malignancies, including pleural mesothelioma and non-small and small cell lung cancers, and is an internationally recognized expert in the development of novel chemotherapy drugs. Education and Career Dr. Socinski earned his medical degree at the University
Dr. Thomas E. Stinchcombe is a medical oncologist at the Duke Cancer Institute and a Professor of Medicine at the Duke School of Medicine in Durham, North Carolina. He specializes in the treatment of thoracic malignancies, including small and non-small cell lung cancer and malignant pleural mesothelioma. Education and Career Dr. Stinchcombe earned his medical
Dr. Rupesh Rajesh Kotecha is a board-certified radiation oncologist at Baptist Health’s Miami Cancer Institute. He has special skills and experience in the use of innovative techniques for both malignant and non-cancerous conditions, including pleural mesothelioma and other thoracic malignancies. Dr. Kotecha performs numerous high-level procedures that leverage advancements in radiation oncology, including: Education and
Dr. Ramesh Rengan is a radiation oncologist at the University of Washington and Fred Hutch Cancer Center. He specializes in radiation treatment of lung cancer and thoracic malignancies, including pleural mesothelioma. In addition to treating patients using innovative radiation tools, Dr. Rengan oversees all cancer programs, research, projects, and activities within the proton therapy center.